AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
_6ff029a61766633234293.png?format=webp&width=1186&height=250)
First Trust Mid Cap Value AlphaDEX Fund ETF: Analysts See 9.97% Upside to $62 Implied Target Price
ByAinvest
Thursday, Aug 28, 2025 8:10 am ET1min read
The First Trust Mid Cap Value AlphaDEX Fund ETF (FNK) has an implied analyst target price of $61.87, with a recent price of $56.26, indicating 9.97% upside. Three underlying holdings with notable upside to their analyst target prices are Caesars Entertainment Inc (CZR), Organon & Co (OGN), and Silgan Holdings Inc (SLGN), with analyst targets of $40.56, $13.17, and $60.60, respectively.
The First Trust Mid Cap Value AlphaDEX Fund ETF (FNK) has recently garnered attention for its notable analyst target prices, indicating potential upside for investors. Among its underlying holdings, Caesars Entertainment Inc (CZR), Organon & Co (OGN), and Silgan Holdings Inc (SLGN) stand out with significant analyst target price discrepancies.Caesars Entertainment Inc (CZR) currently trades at $26.14, with an implied analyst target price of $40.56, representing a 47.3% potential increase. The company reported a loss of $0.39 earnings per share for the latest quarter, missing analysts' consensus estimates of $0.07. Despite the recent earnings miss, Caesars Entertainment has seen increased institutional support, with Banco Bilbao Vizcaya Argentaria S.A. raising its stake by 87.7% to own 34,940 shares valued at $874,000 [1].
Organon & Co (OGN) is trading at $13.17, with an implied analyst target price of $13.17, indicating no immediate upside potential. The company has seen recent analyst target price adjustments, with Macquarie lowering its target from $45.00 to $40.00 and setting an "outperform" rating on the stock [1].
Silgan Holdings Inc (SLGN) is trading at $46.70, with an implied analyst target price of $60.60, representing a 25.8% potential increase. On August 22, 2025, Silgan's EVP of Corporate Development & Administration, Robert B. Lewis, sold 11,000 shares of common stock at $46.7 per share, totaling $513,700. Following the transaction, Lewis directly owns 142,378 shares of Silgan Holdings, including 46,314 restricted stock units pending vesting [2].
Investors should consider the latest earnings reports, analyst ratings, and institutional ownership when evaluating these stocks. The First Trust Mid Cap Value AlphaDEX Fund ETF (FNK) offers exposure to these companies, providing a diversified investment opportunity.
References:
[1] https://www.marketbeat.com/instant-alerts/filing-caesars-entertainment-inc-czr-shares-purchased-by-banco-bilbao-vizcaya-argentaria-sa-2025-08-23/
[2] https://www.tradingview.com/news/tradingview:2f54a824266e6:0-silgan-holdings-evp-sells-11-000-shares/
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet